US05464T1043
US05464T1043
Axsome Therapeutics, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 8.82B EUR | 12.8B EUR | 8.69B EUR |
Enterprise Value | 8.81B EUR | 12.71B EUR | 8.61B EUR |
Valuation Multiples | |||
Trailing P/E | -- | -- | -- |
Forward P/E | 35.8x | -- | -- |
Price to Sales | 11.36x | 16.48x | 12.27x |
Price to Book | 105.68x | 153.67x | 159.22x |
EV/Revenue | 11.35x | 16.36x | 12.15x |
EV/EBITDA | -50.97x | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- |
EV/FCF | -- | -- | -- |
FCF Yield | -0.05% | -0.56% | -0.82% |